Abstract
Saturday, June 18, 20229:30 AM - 10:30 AM GPP06 Presentation Time: 9:30 AM: Image-Guided Cervical Cancer Brachytherapy: Summary of Consensus Recommendations from the Society for Abdominal Radiology and American Brachytherapy Society
Brachytherapy, v 21(6), pp S37-S38
Nov 2022
Abstract
To summarize recommendations regarding imaging guidance for cervical cancer brachytherapy implant placement from the Society of Abdominal Radiology (SAR) and American Brachytherapy Society (ABS).
A comprehensive literature search was conducted on PubMed for image-guided cervical cancer brachytherapy (BT) using radiography, ultrasound (US), computed tomography (CT), and magnetic resonance imaging (MRI). Original research studies were included for evaluation if they included sensitivity and specificity of tumor detection, complication rates, or additional quantitative imaging results directly related to brachytherapy, such as geometric distortion measurements. The literature review was evaluated by an expert panel of members from the Society for Abdominal Radiology (SAR) and American Brachytherapy Society (ABS). These data were analyzed to determine an overall level of evidence for each recommendation and the subsequent strength of each claim.
Three-dimensional (3D) imaging is recommended for treatment planning whenever feasible due to the rate of toxicities ≥ Grade 3 decreasing from between 0-13.5% with 2D planning to 0-5.8% with 3D planning. US guidance is highly recommended for tandem selection and insertion to reduce uterine perforation rates from 2.3-34%/insertion without US-guidance to 0-1.4%/insertion with US. US-guided interstitial needle placement is feasible when post-implant 3D imaging is available for treatment planning. Post-implant CT is recommended over orthogonal radiography to reduce genitourinary and gastrointestinal complications and evaluate proper applicator positioning. Tumor visualization is optimal on T2-weighted (T2w) MRI, which also provides improved specificity for assessment of parametrial invasion. CT-based treatment planning should refer to prior MRI for high risk-clinical target volume (HR-CTV) contouring, when available. Treatment planning on MRI is highly recommended for HR-CTV delineation, and post-applicator imaging should include at minimum both a 2D sagittal T2w and 3D axial T2w fast spin echo-based sequence.
Imaging-guidance for cervical brachytherapy implant placement is now standard-of-care. 3D imaging with MRI is highly recommended for treatment planning purposes, although CT-based planning also results in fewer complications as compared to 2D planning techniques. Ultrasound is useful for applicator placement, but application to treatment planning is limited.
Metrics
4 Record Views
Details
- Title
- Saturday, June 18, 20229:30 AM - 10:30 AM GPP06 Presentation Time: 9:30 AM: Image-Guided Cervical Cancer Brachytherapy: Summary of Consensus Recommendations from the Society for Abdominal Radiology and American Brachytherapy Society
- Creators
- Megan Jacobsen - The University of Texas MD Anderson Cancer CenterSushil Beriwal - Allegheny Health NetworkBrandon A. Dyer - Legacy HealthAnn H. Klopp - The University of Texas MD Anderson Cancer CenterSusanna I. Lee - Massachusetts General HospitalGwendolyn J. McGinnis - The University of Texas MD Anderson Cancer CenterJessica B. Robbins - University of Wisconsin–MadisonGaiane M. Rauch - The University of Texas MD Anderson Cancer CenterElizabeth A. Sadowski - University of Wisconsin–MadisonSamantha J. Simiele - The University of Texas MD Anderson Cancer CenterNeil K. Taunk - University of PennsylvaniaCatheryn M. Yashar - University of California, San DiegoAradhana M. Venkatesan - The University of Texas MD Anderson Cancer Center
- Publication Details
- Brachytherapy, v 21(6), pp S37-S38
- Publisher
- Elsevier
- Resource Type
- Abstract
- Language
- English
- Academic Unit
- Radiation Oncology (and Nuclear Medicine)
- Other Identifier
- 991021897277704721